Skip to main content

Advertisement

Log in

Excessive daytime sleepiness in cancer patients

  • Psychiatrics • Short Communication
  • Published:
Sleep and Breathing Aims and scope Submit manuscript

Abstract

Purpose

Excessive daytime sleepiness (EDS) is commonly reported in patients with cancer, and it is also a cardinal feature of central disorders of hypersomnolence. Multiple sleep latency testing (MSLT) is used for objective assessment.

Methods

A retrospective review of patients with cancer history who underwent formal sleep evaluation and MSLT from 2006 to 2019 was performed. Clinical characteristics, sleep-related history, and polysomnographic data were reviewed.

Results

Of 16 patients with cancer history, 9 were women (56%) and median age was 49. Cancer diagnoses included 4 central nervous system, 3 breast, 1 lymphoma, and 9 other solid malignancies, and 31% were undergoing active treatment. Comorbid conditions included depression, obstructive sleep apnea, and cancer-related fatigue. Daytime fatigue (94%), daily naps (81%), and EDS (69%) were the most common symptoms. Hypnopompic and hypnogogic hallucinations, sleep paralysis, sleep attacks, and cataplexy were present in a few. Epworth Sleepiness Scale scores were consistent with EDS in 88%, and mean sleep latency was less than 8 min in 69%. Only 31% had more than 2 sleep-onset REM periods. MSLT supported diagnoses of central disorders of hypersomnolence in 5 patients (4 narcolepsy, 1 idiopathic hypersomnia); 5 hypersomnia due to a medical disorder, psychiatric condition, or medication; and 6 with normal results. Pharmacotherapy was prescribed in 5 patients.

Conclusions

EDS in patients with cancer may be multifactorial, but persistent symptoms may indicate an underlying disorder of hypersomnolence. Sleep referral and polysomnography to exclude other sleep disorders may be indicated. MSLT can help confirm the diagnosis. In those with normal MSLT, further evaluation for mood disorder should be considered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Davidson JR, MacLean AW, Brundage MD, Schulze K (2002) Sleep disturbance in cancer patients. Soc Sci Med 54:1309–1321

    Article  Google Scholar 

  2. Armstrong TS, Shade MY, Breton G, Gilbert MR, Mahajan A, Scheurer ME, Vera E, Berger AM (2017) Sleep-wake disturbance in patients with brain tumors. Neuro-Oncology 19:323–335

    PubMed  Google Scholar 

  3. Powell C, Guerrero D, Sardell S, Cumins S, Wharram B, Traish D, Gonsalves A, Ashley S, Brada M (2011) Somnolence syndrome in patients receiving radical radiotherapy for primary brain tumours: a prospective study. Radiother Oncol 100:131–136

    Article  Google Scholar 

  4. Dauvilliers Y (2006) Differential diagnosis in hypersomnia. Curr Neurol Neurosci Rep 6:156–162

    Article  Google Scholar 

  5. Autret A, Lucas B, Mondon K, Hommet C, Corcia P, Saudeau D, de Toffol B (2001) Sleep and brain lesions: a critical review of the literature and additional new cases. Neurophysiol Clin 31:356–375

    Article  CAS  Google Scholar 

  6. Weil AG, Muir K, Hukin J, Desautels A, Martel V, Perreault S (2018) Narcolepsy and hypothalamic region tumors: presentation and evolution. Pediatr Neurol 84:27–31

    Article  Google Scholar 

  7. Berger AM (2009) Update on the state of the science: sleep-wake disturbances in adult patients with cancer. Oncol Nurs Forum 36:E165–E177

    Article  Google Scholar 

  8. Sateia MJ (2014) International classification of sleep disorders-third edition: highlights and modifications. Chest 146:1387–1394

    Article  Google Scholar 

  9. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42:377–381

    Article  Google Scholar 

  10. Lopez E, de la Torre-Luque A, Lazo A, Alvarez J, Buela-Casal G (2016) Assessment of sleep disturbances in patients with cancer: cross-sectional study in a radiotherapy department. Eur J Oncol Nurs 20:71–76

    Article  Google Scholar 

  11. Cleeland CS, Bennett GJ, Dantzer R, Dougherty PM, Dunn AJ, Meyers CA, Miller AH, Payne R, Reuben JM, Wang XS, Lee BN (2003) Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer 97:2919–2925

    Article  Google Scholar 

  12. Charalambous A, Berger AM, Matthews E, Balachandran DD, Papastavrou E, Palesh O (2019) Cancer-related fatigue and sleep deficiency in cancer care continuum: concepts, assessment, clusters, and management. Support Care Cancer 27:2747–2753

    Article  Google Scholar 

  13. Berger AM, Hertzog M, Geary CR, Fischer P, Farr L (2012) Circadian rhythms, symptoms, physical functioning, and body mass index in breast cancer survivors. J Cancer Surviv 6:305–314

    Article  Google Scholar 

  14. Irwin MR, Olmstead RE, Ganz PA, Haque R (2013) Sleep disturbance, inflammation and depression risk in cancer survivors. Brain Behav Immun 30(Suppl):S58–S67

    Article  Google Scholar 

  15. Dauvilliers Y, Lopez R, Ohayon M, Bayard S (2013) Hypersomnia and depressive symptoms: methodological and clinical aspects. BMC Med 11:78

    Article  Google Scholar 

  16. Zhai L, Zhang H, Zhang D (2015) Sleep duration and depression among adults: a meta-analysis of prospective studies. Depress Anxiety 32:664–670

    Article  Google Scholar 

  17. Davis MP, Behm B, Balachandran D (2017) Looking both ways before crossing the street: assessing the benefits and risk of opioids in treating patients at risk of sleep -disordered breathing for pain and dyspnea. J Opioid Manag 13:183–196

    Article  Google Scholar 

Download references

Acknowledgments

We would like to thank the members of the sleep center (Leendert Keus, Ashley S. Knox, Stephen Mahoney, Gloria Oyekanmi, John N. Po) for their participation in the diagnostic study and clinical care of these patients.

Funding

This research is supported in part by the National Institutes of Health through MD Anderson’s Cancer Center Support Grant (CA016672).

Author information

Authors and Affiliations

Authors

Contributions

BJ and SF had full access to all of the data in the study and take responsibility for the integrity of the data and accuracy of the data analysis and editing and writing of the manuscript; GP contributed substantially to study design, data collection, data analysis, and interpretation; AD, NC, RM, LB, and DB contributed substantially to data analysis and interpretation and editing of the manuscript.

Corresponding author

Correspondence to Saadia A. Faiz.

Ethics declarations

Conflict of interest disclosures

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments.

Informed consent

This type of study does not require informed consent.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jaumally, B.A., Das, A., Cassell, N.C. et al. Excessive daytime sleepiness in cancer patients. Sleep Breath 25, 1063–1067 (2021). https://doi.org/10.1007/s11325-020-02151-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11325-020-02151-9

Keywords

Navigation